MillerKnoll (MLKN) Q4 2025: $55M Order Pull Forward Masks Core Contract Momentum

MillerKnoll delivered a robust Q4, yet a $55M-$60M order pull forward ahead of tariff surcharges clouds underlying demand clarity. Gross margin resilience and disciplined retail expansion signal operational strength, but Q1 faces near-term margin headwinds as backlog normalizes and tariffs weigh on cost of goods. Investor focus now shifts to the pace of contract recovery and retail maturation as macro and tariff dynamics evolve.

Summary

  • Tariff-Driven Order Surge: Q4 order strength was amplified by customers accelerating purchases to avoid impending price hikes.
  • Retail Expansion Balances Growth and Margin: Aggressive store openings will pressure near-term retail margins, but management sees white space and long-term profitability upside.
  • Margin Compression and Recovery: Tariff costs and timing of price realization will weigh on Q1 and Q2, with margin recovery expected in the second half of fiscal 2026.

Performance Analysis

MillerKnoll’s Q4 results outpaced internal expectations, with consolidated net sales rising 8.2% year-over-year to $962 million. The standout was North America contract, which posted nearly 13% sales growth and 16% order growth, though management attributed $55M-$60M of this to demand being pulled forward in anticipation of tariff-related surcharges and price increases. Even after normalizing for this effect, underlying contract demand still posted mid-single-digit growth, supported by strong activity in public sector and healthcare verticals. International contract sales rose 6.9%, with Europe and Latin America leading growth, and retail sales edged up 2.2%, with new store openings driving topline expansion.

Gross margin held firm at 39.2%, up 130 basis points sequentially but down slightly year-over-year, as $7 million in tariff-related costs weighed on profitability. Operating margins improved in contract, especially North America (up to 7.7%), but retail margins dipped to 5.3% due to new store opening costs and unfavorable mix. Cash flow from operations reached $71 million, and the company reduced net debt, ending the year with $576 million in liquidity and a net debt-to-EBITDA ratio of 2.88x.

  • Order Book Volatility: Q4’s $1.04B in new orders (up 11.1%) was skewed by pull-forward, with Q1 orders tracking down mid-single digits so far.
  • Retail Margin Drag: Ongoing store investments and new market entry are expected to keep retail margins at current low-single-digit levels until stores mature.
  • Tariff Impact: Tariffs are projected to reduce Q1 earnings by $9M-$11M, with price increases offsetting costs in the second half.

Management’s tone is confident on underlying demand and strategic levers, but near-term results will be shaped by backlog normalization, tariff absorption, and retail ramp-up costs.

Executive Commentary

"We are very pleased with our strong finish to fiscal 2025, with our Q4 results significantly exceeding our expectations... In our contract businesses, we made incredible progress, and we have multiple opportunities to grow our market share, both in North America and internationally."

Andy Owen, Chief Executive Officer

"In the fourth quarter, we generated adjusted earnings of $0.60 per share, significantly outperforming the midpoint of our guidance, driven by better than expected sales and strong gross margin performance that benefited from leverage on our sales growth... Given the volume of orders pulled forward ahead of our price surcharge and the normal time it takes to begin benefiting from list price changes in our contract businesses, we expect margins to be negatively impacted in the near term by tariffs currently in place, but remain confident our pricing actions will offset these later in the fiscal 2026."

Jeff Stetz, Chief Financial Officer

Strategic Positioning

1. Contract Segment Demand and Competitive Leverage

North America contract remains the core engine, with public sector and healthcare verticals driving growth. The $55M-$60M order pull forward distorts near-term optics, but underlying demand indicators—such as pricing requests (up 35% YoY) and contract activations (up 50% YoY)—suggest sustained customer engagement. Management highlights flagship showrooms, design leadership, and a broad product portfolio as key competitive differentiators, positioning the company to capture market share as office utilization and leasing activity recover.

2. Retail Footprint Expansion and Maturation Timeline

Retail expansion is a multi-year growth lever, with 10-15 new stores planned in fiscal 2026. Management’s confidence is rooted in “white space” opportunity and low current store penetration versus peers. However, store opening costs and maturation lag will keep retail margins at 5% in the near term, with profitability expected to ramp as the fleet matures and assortment broadens. The “halo effect” of new stores on e-commerce and brand awareness is cited as an incremental benefit.

3. Tariff and Price Action Dynamics

Tariff headwinds are acute in Q1 and Q2, as most of the Q4 backlog was booked pre-surcharge, delaying the benefit of price increases. Management expects the bulk of tariff impact to be absorbed by mid-year, with pricing actions restoring margin in the second half. Approximately 17-19% of cost of goods sold is exposed to import tariffs, underscoring the importance of ongoing mitigation efforts and pricing agility.

4. Capital Allocation and Financial Flexibility

Disciplined capital allocation is a strategic priority, with a shift from opportunistic share buybacks in fiscal 2025 to increased CapEx for store buildout and debt reduction in fiscal 2026. The company’s liquidity position and extended credit facility maturities provide a buffer against macro and geopolitical volatility.

5. Innovation and Vertical Diversification

Targeted R&D and product launches in healthcare, higher education, and gaming are intended to diversify revenue streams and reduce cyclicality. The debut of the GEMMA Healthcare Seating Family and the Dividend Skyline system exemplify management’s focus on differentiated, recession-resilient verticals.

Key Considerations

This quarter underscores MillerKnoll’s ability to execute through volatility, but the sustainability of contract demand and the pace of retail margin recovery are critical watchpoints. Investors should weigh short-term headwinds against the company’s multi-pronged growth strategy and financial discipline.

Key Considerations:

  • Order Normalization Risk: Q1 order softness is expected as the Q4 pull forward unwinds, with visibility into underlying demand improving by Q2.
  • Retail Store Maturation Curve: New stores require 2-6 months from possession to opening and reach profitability within the first year, but drag on margins until mature.
  • Margin Recovery Timing: Tariff-related margin compression will persist through Q2, with full pricing benefit realized in the back half of fiscal 2026.
  • Capital Discipline Amid Expansion: CapEx will rise to $120-$130M for store buildout, with a parallel focus on debt reduction to preserve balance sheet strength.
  • Vertical and Geographic Mix: Public sector, healthcare, and international markets provided resilience, offsetting softness in banking and retail margin pressure.

Risks

Tariff and geopolitical volatility remain key risks, with up to 19% of cost of goods exposed to import tariffs. Prolonged margin compression could pressure earnings if price realization lags or macro conditions deteriorate. Retail expansion in a soft housing market may extend the path to margin normalization, while competitive intensity and promotional activity could erode pricing power in core segments.

Forward Outlook

For Q1 fiscal 2026, MillerKnoll guided to:

  • Net sales of $899M to $939M (midpoint up 6.7% YoY)
  • Gross margin of 37.1% to 38.1%
  • Adjusted diluted EPS of $0.32 to $0.38

Management is limiting guidance to Q1 due to tariff and macro uncertainty, but expects tariff headwinds to subside by the second half as price actions take hold. Store opening costs will persist throughout the year, with retail profitability improving as the fleet matures.

  • Tariff mitigation and pricing actions are expected to fully offset costs by Q3/Q4.
  • Retail margins to remain at current levels until new stores mature and assortment expands.

Takeaways

The quarter demonstrated MillerKnoll’s operational agility, but also highlighted the challenges of managing through external shocks. The company’s long-term growth thesis—anchored in contract share gains, retail expansion, and vertical innovation—remains intact, but margin trajectory and demand normalization will be scrutinized in coming quarters.

  • Order Book Volatility: The Q4 surge was not purely organic, so investors should expect Q1 softness before a clearer trend emerges.
  • Retail Profitability Path: The margin drag from new stores is a deliberate investment, with management targeting mid-teens operating margins over time as the fleet scales and matures.
  • Margin Recovery Watch: Successful pass-through of tariff costs and sustained contract funnel strength are critical for margin and earnings recovery in the back half of fiscal 2026.

Conclusion

MillerKnoll’s Q4 headline strength was buoyed by tariff-driven order acceleration, but underlying demand and margin normalization will be tested as the year unfolds. Disciplined capital allocation and strategic expansion position the company for long-term gains, but investors should monitor the pace of retail maturation and the effectiveness of tariff mitigation as key drivers of value realization.

Industry Read-Through

The Q4 order pull forward at MillerKnoll is a cautionary signal for contract furniture peers—tariff and price action timing can distort short-term demand and backlog visibility. Retail expansion strategies across home furnishings remain challenged by macro uncertainty and slow housing markets, suggesting margin headwinds for those scaling store fleets. Tariff exposure and the ability to execute pricing actions will be a sector-wide margin differentiator, while vertical diversification into healthcare, public sector, and international markets is emerging as a resilience playbook for industry leaders.